{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:56:49Z","timestamp":1775509009129,"version":"3.50.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"9664","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/s0140-6736(09)60008-8","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T19:20:22Z","timestamp":1232565622000},"page":"659-672","source":"Crossref","is-referenced-by-count":740,"title":["Rheumatoid arthritis"],"prefix":"10.1016","volume":"373","author":[{"given":"Lars","family":"Klareskog","sequence":"first","affiliation":[]},{"given":"Anca Irinel","family":"Catrina","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Paget","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(09)60008-8_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","article-title":"Comorbidities in rheumatoid arthritis","volume":"21","author":"Michaud","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/keh210","article-title":"Rheumatoid vasculitis: becoming extinct?","volume":"43","author":"Watts","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S0140-6736(09)60008-8_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s100670050068","article-title":"Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland","volume":"18","author":"Laiho","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/art.10167","article-title":"Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort","volume":"46","author":"Bukhari","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","article-title":"Use and significance of anti-CCP autoantibodies in rheumatoid arthritis","volume":"45","author":"Zendman","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S0140-6736(09)60008-8_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(09)60008-8_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.1780390504","article-title":"Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins","volume":"39","author":"Silman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/bmj.326.7398.1068","article-title":"Perinatal characteristics and risk of rheumatoid arthritis","volume":"326","author":"Jacobsson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(09)60008-8_bib12","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1002\/art.20621","article-title":"Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study","volume":"50","author":"Karlson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib13","doi-asserted-by":"crossref","first-page":"19966","DOI":"10.1073\/pnas.0710260104","article-title":"Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development","volume":"104","author":"Feitsma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(09)60008-8_bib14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1172\/JCI108382","article-title":"Mixed lymphocyte cultures in rheumatoid arthritis","volume":"57","author":"Stastny","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(09)60008-8_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(09)60008-8_bib16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.gene.6364159","article-title":"The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status","volume":"6","author":"Lee","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/S0140-6736(09)60008-8_bib18","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1371\/journal.pmed.0040278","article-title":"A candidate gene approach identifies the TRAF1\/C5 region as a risk factor for rheumatoid arthritis","volume":"4","author":"Kurreeman","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ng.2007.27","article-title":"Two independent alleles at 6q23 associated with risk of rheumatoid arthritis","volume":"39","author":"Plenge","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/2007-00123.Lee","article-title":"Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus","volume":"14","author":"Lee","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib22","unstructured":"Ding B, Padyukov L, Lundstr\u00f6m E, et al. Different patterns of associations with ACPA-positive and ACPA-negative rheumatoid arthritis in the extended MHC region. Arthritis Rheum (in press)."},{"key":"10.1016\/S0140-6736(09)60008-8_bib23","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib24","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/art.22813","article-title":"Association of arthritis with a gene complex encoding C-type lectin-like receptors","volume":"56","author":"Lorentzen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib25","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib28","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/art.21272","article-title":"An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility","volume":"52","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib29","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","article-title":"Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England","volume":"40","author":"Symmons","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib30","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2005.041079","article-title":"Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles","volume":"65","author":"Linn-Rasker","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib33","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","article-title":"Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark","volume":"56","author":"Pedersen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib34","doi-asserted-by":"crossref","first-page":"R1296","DOI":"10.1186\/ar1824","article-title":"Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study","volume":"7","author":"Sverdrup","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(09)60008-8_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.52.12.897-b","article-title":"Alcohol, androgens and arthritis","volume":"52","author":"Aho","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.0608620104","article-title":"Ethanol prevents development of destructive arthritis","volume":"104","author":"Jonsson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(09)60008-8_bib37","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(09)60008-8_bib38","article-title":"Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies","author":"Kallberg","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib40","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.79.11.3632","article-title":"Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis","volume":"79","author":"Klareskog","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(09)60008-8_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM197509112931101","article-title":"Predominantly T-cell infiltrate in rheumatoid synovial membranes","volume":"293","author":"Van Boxel","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib43","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.179.7.4704","article-title":"Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes","volume":"179","author":"Rieck","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib44","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2384","article-title":"Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets","volume":"10","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(09)60008-8_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0010-7824(87)90082-5","article-title":"Oral contraceptives, cigarette smoking and other factors in relation to arthritis","volume":"35","author":"Vessey","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/S0140-6736(09)60008-8_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D","article-title":"A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals","volume":"42","author":"Karlson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib49","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/bmj.294.6578.997","article-title":"Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940\u201381","volume":"294","author":"Klockars","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(09)60008-8_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/oem.2003.007971","article-title":"Occupations and exposures in the work environment as determinants for rheumatoid arthritis","volume":"61","author":"Olsson","year":"2004","journal-title":"Occup Environ Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib51","first-page":"1111","article-title":"Rheumatoid disease and pneumoconiosis (Caplan's syndrome)","volume":"52","author":"Caplan","year":"1959","journal-title":"Proc R Soc Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/03009740600718080","article-title":"Risk factors for the development of rheumatoid arthritis","volume":"35","author":"Oliver","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib53","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/art.22703","article-title":"Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2249.2006.03154.x","article-title":"Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers","volume":"145","author":"Lofdahl","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S0140-6736(09)60008-8_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20072051","article-title":"Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice","volume":"205","author":"Hill","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib59","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib60","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib61","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","article-title":"Citrullination is an inflammation-dependent process","volume":"65","author":"Makrygiannakis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib62","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(09)60008-8_bib63","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.4049\/jimmunol.168.8.4164","article-title":"Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA\/1j mice","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib68","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.berh.2006.06.004","article-title":"Is IL-1 a good therapeutic target in the treatment of arthritis?","volume":"20","author":"Burger","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2567.1999.00772.x","article-title":"Do self-perpetuating B lymphocytes drive human autoimmune disease?","volume":"97","author":"Edwards","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/S0140-6736(09)60008-8_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0140-6736(09)60008-8_bib71","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/35068632","article-title":"Inflammatory response: pathway across the blood-brain barrier","volume":"410","author":"Ek","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(09)60008-8_bib73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.21838","article-title":"Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis","volume":"55","author":"Moreland","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib74","first-page":"417","article-title":"Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study","volume":"25","author":"Plant","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib75","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib76","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(09)60008-8_bib77","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar2166","article-title":"Erosive arthritis","volume":"9","author":"Schett","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(09)60008-8_bib78","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","article-title":"Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis","volume":"54","author":"Jarrett","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/ar2304","article-title":"Proteinases in the joint: clinical relevance of proteinases in joint destruction","volume":"9","author":"Rengel","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(09)60008-8_bib80","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib81","first-page":"841","article-title":"Taking mortality in rheumatoid arthritis seriously: predictive markers, socioeconomic status and comorbidity","volume":"13","author":"Pincus","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib82","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: a retrospective cohort study from disease onset","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib84","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.0000168055.89955.db","article-title":"Arterial stiffness in chronic inflammatory diseases","volume":"46","author":"Roman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/S0140-6736(09)60008-8_bib86","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib87","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2006.061002","article-title":"Consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"66","author":"Smolen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib89","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"suppl 2","key":"10.1016\/S0140-6736(09)60008-8_bib91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02203393","article-title":"The present and future of comprehensive outcome measures for rheumatic diseases","volume":"6","author":"Spitz","year":"1987","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib92","first-page":"1","article-title":"It's good to feel better but it's better to feel good","volume":"32","author":"Dougados","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib93","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.rdc.2005.07.004","article-title":"Conventional x-ray in early arthritis","volume":"31","author":"Boonen","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/S0140-6736(09)60008-8_bib94","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard.2007.074708","article-title":"Does extremity-MRI improve erosion detection in severely damaged joints? A study of long-standing rheumatoid arthritis using three imaging modalities","volume":"66","author":"Freeston","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib95","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.20333","article-title":"Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination","volume":"50","author":"Szkudlarek","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib96","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O'Dell","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis","volume":"350","author":"Boers","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib98","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial","volume":"353","author":"M\u00f6tt\u00f6nen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib99","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/art.21298","article-title":"Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial","volume":"52","author":"Svensson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib100","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"10.1016\/S0140-6736(09)60008-8_bib101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0896-8411(89)90129-7","article-title":"Cytokine production in culture by cells isolated from the synovial membrane","volume":"2","author":"Brennan","year":"1989","journal-title":"J Autoimmun"},{"key":"10.1016\/S0140-6736(09)60008-8_bib102","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib103","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib104","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib105","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib107","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib108","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/art.22143","article-title":"Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes","volume":"54","author":"Landewe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib109","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"Smolen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5\u2032-nucleotidase: findings in a study of ecto-5\u2032-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S0140-6736(09)60008-8_bib112","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ard.2004.026120","article-title":"Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis","volume":"64","author":"Lange","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib113","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib114","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","article-title":"New therapies for treatment of rheumatoid arthritis","volume":"370","author":"Smolen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(09)60008-8_bib116","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib117","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(09)60008-8_bib118","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/ard.59.6.439","article-title":"Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment","volume":"59","author":"Ulfgren","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib119","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/ard.2007.080440","article-title":"The clinical response to infliximab in rheumatoid arthritis is in part dependent on pre-treatment TNF\u03b1 expression in the synovium","volume":"67","author":"Wijbrandts","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib120","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1002\/art.22967","article-title":"Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment","volume":"56","author":"Teng","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.berh.2006.08.011","article-title":"Early rheumatoid arthritis: strategies for prevention and management","volume":"21","author":"Combe","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib122","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11926-007-0066-2","article-title":"Switching anti-TNF-alpha agents: what is the evidence?","volume":"9","author":"Erickson","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/S0140-6736(09)60008-8_bib123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","article-title":"COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention","volume":"46","author":"Landewe","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2 suppl","key":"10.1016\/S0140-6736(09)60008-8_bib124","first-page":"S126","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"58","author":"Goekoop-Ruiterman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/BOR.0b013e3282f50eb1","article-title":"The role of drug and disease registries in rheumatic disease epidemiology","volume":"20","author":"Kremer","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib127","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","article-title":"Infections in patients with rheumatoid arthritis treated with biologic agents","volume":"52","author":"Listing","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib128","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib129","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0b013e3282f7c706","article-title":"Malignancy and biologic therapy in rheumatoid arthritis","volume":"20","author":"Askling","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S0140-6736(09)60008-8_bib130","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib131","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(09)60008-8_bib132","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/ard.2007.074773","article-title":"Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy","volume":"67","author":"Genovese","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(09)60008-8_bib133","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(09)60008-8_bib134","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":"Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"suppl 3","key":"10.1016\/S0140-6736(09)60008-8_bib135","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1136\/ard.2007.081430","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007","volume":"66","author":"Furst","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673609600088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673609600088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:07:37Z","timestamp":1738897657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673609600088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":134,"journal-issue":{"issue":"9664","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0140673609600088"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(09)60008-8","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}